(The Epoch Times)—Senate Minority Leader Chuck Schumer (D-N.Y.) said Sunday that he will not step down as the Senate’s Democratic leader amid internal party criticism over his decision to support a Republican-backed funding bill to avoid a government shutdown earlier this month.
“Look, I’m not stepping down,” Schumer said in an interview with NBC’s “Meet the Press,” adding that he knew that voting for the funding measure would trigger “a lot of controversy” among members of his own party.
Schumer then explained the rationale behind his vote. “Sometimes when you’re a leader, you have to do things to avoid a real danger that might come down the curve,” he told the outlet.
“And I did it out of pure conviction as to what a leader should do and what the right thing for America and my party was,” he continued. “People disagree.”
Democrats last week were confronted with two options, including allowing passage of a bill they believe gave President Donald Trump vast discretion on spending decisions or letting funding lapse. After Schumer said he’d vote to advance the spending measure, 10 Democrats supported breaking the 60-vote filibuster threshold, allowing the bill to pass.
The controversy that ensued among Democrats prompted Schumer last week to postpone his book tour amid a series of planned progressive demonstrations.
Several House Democrats, including members of the progressive wing, have been critical of Schumer’s vote and have suggested that he step down.
“The American people are fed up with the old guard, there needs to be a renewal,” Rep. Ro Khanna (D-Calif.) told CNN on Sunday. “You know, in Silicon Valley, when a company isn’t doing well, you don’t keep the same team.”
“And I think there’s going to be a new generation in this country,” the California Democrat said, responding to a question on whether Schumer should remain leader.
Earlier this month, Rep. Alexandria Ocasio-Cortez (D-N.Y.) targeted Schumer for saying he would vote to back the bill.
“There is a deep sense of outrage and betrayal,” Ocasio-Cortez told reporters, adding that “this is not just about progressive Democrats,” and accused Schumer of betraying “the entire party.”
Days later, Rep. Glenn Ivey (D-Md.) told NewsNation that he respects Schumer but suggested that “it may be time for Senate Democrats to choose a new leader,” responding to a question about whether he should step down.
In an interview that also aired Sunday on ABC’s “This Week,” Sen. Bernie Sanders (I-Vt.), who caucuses with Democrats, criticized Schumer and other members of Democratic leadership in the Senate. But he abruptly ended the interview when asked about Ocasio-Cortez potentially being elected to the Senate, as some pundits have suggested.
“I don’t want to talk about inside-the-beltway stuff,” Sanders said in response to questioning about Schumer’s position.
“We could have, in my view, perhaps gotten [Republicans] to agree to a third way,” she told reporters last week, making reference to a separate proposal by some Democrats to extend spending by another 30 days to secure more talks with Republicans, who hold majorities in both chambers.
Schumer isn’t up for reelection until 2028. The other U.S. senator from New York, Sen. Kirsten Gillibrand (D-N.Y.), was reelected in the 2024 election and isn’t up for reelection until 2030.
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.